-
HD2026 Milton Wexler Biennial Symposium Day 3
Latest News
-
HD2026 Milton Wexler Biennial Symposium Day 2
⏱️ 23 min read | Day 2 of #HD2026 brought us updates on the mechanics of somatic instability, new ways to track HD in people, AI tools to help drive research forward, and developments in our understanding of the HTT protein. Catch up right here.
-
TRACK-HD reveals significant changes in pre-symptomatic HD mutation carriers and patients
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Novartis/PTC Therapeutics
Expected:
Spring 2026
Show 9 more Show less
REGEN4HD, Phase 1 stem cell implantation study commences
University of California, Irvine
Expected:
Not disclosed
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Alnylam Pharmaceuticals
Expected:
2026
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Skyhawk Therapeutics
Expected:
Not disclosed